TRCT
IVA

Tower Research Capital (TRC)’s Inventiva IVA Stock Holding History

Tower Research Capital (TRC)’s Portfolio IVA Stock Details IVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.8K Buy
+1,800
New +$8.65K ﹤0.01% 4178

Other funds holding IVA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM

Tower Research Capital (TRC)'s IVA Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in Inventiva (IVA) in Q2 2026: 1,800 shares worth $6.8K. The stake represents ﹤0.01% of the portfolio and ranks #4178 among its holdings.

88 funds tracked by Wall St. Rank hold IVA as of Q2 2026.

  • Tower Research Capital (TRC) held 1,800 shares of Inventiva worth $6.8K as of Q2 2026.
  • Inventiva was a new Tower Research Capital (TRC) position in Q2 2026.
  • Inventiva made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4178 holding.
  • 88 funds tracked by Wall St. Rank held Inventiva as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.